Showing 21 - 40 results of 193 for search '"fax"', query time: 0.04s Refine Results
  1. 21

    Insufficient Evidence to Recommend Shu Mian Capsule in Managing Depression With or Without Comorbid Insomnia: A Systematic Review With Meta-Analysis and Trial Sequential Analysis by Zhao FY, Xu P, Kennedy GA, Jin X, Wang YM, Zhang WJ, Yue LP, Ho YS, Fu QQ, Conduit R

    Published 2025-01-01
    “…Fei-Yi Zhao,1– 3,* Peijie Xu,4,* Gerard A Kennedy,2,* Xiaochao Jin,5,6 Yan-Mei Wang,3 Wen-Jing Zhang,3 Li-Ping Yue,1 Yuen-Shan Ho,7 Qiang-Qiang Fu,8 Russell Conduit2 1Department of Nursing, School of International Medical Technology, Shanghai Sanda University, Shanghai, 201209, People’s Republic of China; 2School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia; 3Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People’s Republic of China; 4School of Computing Technologies, RMIT University, Melbourne, VIC, 3000, Australia; 5Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; 6Shanghai Jiaotong University School of Nursing, Shanghai, People’s Republic of China; 7School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, People’s Republic of China; 8Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yuen-Shan Ho, School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, People’s Republic of China, Tel +852 2766-6410, Fax +852 2364-9663, Email janice.ys.ho@polyu.edu.hk Qiang-Qiang Fu, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, People’s Republic of China, Tel + 86 021-6569 0520, Fax + 86 021-6569 6249, Email qiangqiang.fu@tongji.edu.cnAim: This systematic review with trial sequential analysis (TSA) aims to evaluate the efficacy and safety of Shu Mian Capsule (SMC), a commercial Chinese polyherbal preparation, for managing depression with or without comorbid insomnia.Methods: Controlled clinical trials assessing SMC against waitlist control, placebo or active controls, or as an adjunct treatment were searched across seven databases. …”
    Get full text
    Article
  2. 22
  3. 23
  4. 24
  5. 25

    Factors Influencing the Willingness of Hospitalized Children’s Parents to Engage in Patient Safety: A Cross-Sectional Study by Kim Y, Chang M

    Published 2025-01-01
    “…Yujeong Kim,1,* Mingi Chang2,* 1College of Nursing, Research Institute of Nursing Innovation, Kyungpook National University, Daegu, Republic of Korea; 2College of Nursing, Kyungpook National University, Daegu, Republic of Korea*These authors contributed equally to this workCorrespondence: Mingi Chang, College of Nursing, Kyungpook National University, 680 Gukchabosangro, Jung-Gu, Daegu, Republic of Korea, 41944, Tel +82-10-6612-9192, Fax +82-53-425-1258, Email mingi4313@naver.comBackground: Hospitalized children’s patient safety incidents can have a significant long-term impact on their physical, psychological, cognitive, and social development. …”
    Get full text
    Article
  6. 26

    Papular Acantholytic Dyskeratosis of the Vulva: A Case Report and Literature Review by Sakpuwadol N, Suchonwanit P

    Published 2025-01-01
    “…Nawara Sakpuwadol, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat Suchonwanit, Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand, Tel +66-2-2011141, Fax +66-2-201-1211 Ext 4, Email poonkiat@hotmail.comAbstract: Papular acantholytic dyskeratosis (PAD) of the vulva is an uncommon benign condition characterized by multiple hyperkeratotic papules in the anogenital region. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29

    Dosimetry Assessment of Potential Hazard from Visible Light, Especially Blue Light, Emitted by Screen of Devices in Daily Use by Charoenpipatsin N, Yothachai P, Nuntawisuttiwong N, Wongpraparut O, Choosri P, Silpa-archa N

    Published 2025-01-01
    “…Norramon Charoenpipatsin,1 Punyanut Yothachai,1 Nuttaporn Nuntawisuttiwong,1 Ornnicha Wongpraparut,2 Pranomkorn Choosri,3 Narumol Silpa-archa1 1Photodermatology Unit, Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Shrewsbury International School Bangkok, Bangkok, Thailand; 3Department of Biomedical Engineering, College of Health Sciences, Christian University of Thailand, Nakhon Pathom, ThailandCorrespondence: Narumol Silpa-archa, Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand, Tel +66 2419 4333, Fax +66 2411 5031, Email doctornarumol@gmail.comAbstract: Visible light has been considered to have minimal impact on the skin. …”
    Get full text
    Article
  10. 30
  11. 31

    Obstacles to Early Diagnosis of Gaucher Disease by Nishimura S, Ma C, Sidransky E, Ryan E

    Published 2025-01-01
    “…Samantha Nishimura,* Charis Ma,* Ellen Sidransky, Emory Ryan National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA*These authors contributed equally to this workCorrespondence: Ellen Sidransky, National Human Genome Research Institute, National Institutes of Health, Building 35A -1E623 Convent Drive, MSC 3708, Bethesda, MD, 20892-3708, USA, Tel +1-301-451-0901, Fax +301-402-6438, Email sidranse@nih.govAbstract: Gaucher disease (GD) is a rare lysosomal storage disorder resulting from a deficiency of the lysosomal enzyme glucocerebrosidase caused by biallelic variants in the GBA1 gene. …”
    Get full text
    Article
  12. 32
  13. 33
  14. 34

    Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review by Gao A, Tian X, Lang D, Chen Y

    Published 2025-01-01
    “…Aili Gao, Xin Tian, Dexiu Lang, Yue Chen Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Yue Chen, Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, People’s Republic of China, Tel/Fax +86-020-83593472, Email cheny767@mail3.sysu.edu.cnAbstract: Scleromyxedema (SM) is a rare primary cutaneous mucinosis characterized by systemic papules and scleroderma-like manifestations, often associated with monoclonal gammopathy. …”
    Get full text
    Article
  15. 35
  16. 36

    Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity by Namasondhi A, Rutnin S, Jerasutus S, Boonsakan P, Triyangkulsri K

    Published 2025-01-01
    “…Amornrut Namasondhi,1 Suthinee Rutnin,1 Suthep Jerasutus,1 Paisarn Boonsakan,2 Korn Triyangkulsri1 1Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Korn Triyangkulsri, Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand, Tel +66-2-2011141, Fax +66-2-201-1211, Email korn.triy@gmail.comAbstract: Lymphomatoid papulosis (LyP) is currently categorized as a primary lymphoproliferative disorder that follows a chronic, recurrent clinical course. …”
    Get full text
    Article
  17. 37

    Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives by Bujnak AC, File B, Tewari KS

    Published 2025-01-01
    “…Alyssa C Bujnak,1 Brittany File,2 Krishnansu S Tewari1 1Department of Gynecologic Oncology, University of California, Irvine-Medical Center, Orange, California, USA; 2Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, Orange, California, USACorrespondence: Alyssa C Bujnak, University of California, Irvine-Medical Center, 3800 West Chapman Avenue, Suite 3400, Orange, CA, USA, Tel +1 714 456-8888, 92868, Fax +1 714 509-2257, Email abujnak@hs.uci.eduAbstract: Endometrial cancer (EC) is the most common gynecologic cancer in developed nations with reported 420,368 new cases worldwide in 2022 and resulting in 97,723 deaths that year; it is also one of the few cancers with expected increases in incidence and mortality, which are expected to increase by 50% and 70%, respectively, by 2045. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40